What should we recommend to our patients with NAFLD regarding alcohol use?
about
Non-alcoholic fatty liver disease: what the clinician needs to know.Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD)Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver diseaseCholine and Fructooligosaccharide: Non-alcoholic Fatty Liver Disease, Cardiac Fat Deposition, and Oxidative Stress Markers.The Utility of Commonly Used Laboratory Tests to Screen for Excessive Alcohol Use in Clinical Practice.Association between alcohol consumption and plasma fetuin-A and its contribution to incident type 2 diabetes in women.Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis.Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers.Mortality associated with alcohol-related liver disease.EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.Liver Cholestasis Secondary to Syphilis in an Immunocompetent Patient
P2860
Q24563068-2FBCAE16-5AF3-4664-9C57-5EB1799EF41BQ27021000-549AB67C-CE4D-4612-BCFF-5CACAEE82650Q34502294-33C84DE2-83BF-468E-A40F-122FE8948C24Q35147488-475A9618-16E5-4051-AFC2-42B95C405475Q35513535-1A740FD4-3F07-4522-A17F-A9A91F7960E7Q35586085-CF01ABAB-E57D-4694-9F2A-2E3AB92917DDQ35889521-840DB22B-4726-47A6-A1D8-F526D8AC1DD7Q37381261-1EFE43C6-D8DD-418F-86E2-A5F7942E7637Q37575764-029B12F4-760C-4C77-8644-6CBCD9402C8CQ37690723-4E8FF140-51C3-4A61-A8F9-63B5377FD39DQ38676257-B033946C-B21F-4305-9537-EBF473919BBEQ38959081-0608C2FB-1C06-425F-A470-B9001AF64DAFQ51220980-3D3DD125-5EAA-4493-98DA-6FAA4FB82A3DQ55497819-90AC65A9-5F25-437F-B190-DEDACA61D3A3Q58693994-03FE5240-010F-4E89-94EF-B56E4D75FF91
P2860
What should we recommend to our patients with NAFLD regarding alcohol use?
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
What should we recommend to our patients with NAFLD regarding alcohol use?
@ast
What should we recommend to our patients with NAFLD regarding alcohol use?
@en
What should we recommend to our patients with NAFLD regarding alcohol use?
@nl
type
label
What should we recommend to our patients with NAFLD regarding alcohol use?
@ast
What should we recommend to our patients with NAFLD regarding alcohol use?
@en
What should we recommend to our patients with NAFLD regarding alcohol use?
@nl
prefLabel
What should we recommend to our patients with NAFLD regarding alcohol use?
@ast
What should we recommend to our patients with NAFLD regarding alcohol use?
@en
What should we recommend to our patients with NAFLD regarding alcohol use?
@nl
P2860
P356
P1476
What should we recommend to our patients with NAFLD regarding alcohol use?
@en
P2093
Naga Chalasani
Suthat Liangpunsakul
P2860
P356
10.1038/AJG.2012.20
P407
P577
2012-07-01T00:00:00Z